In addition to these anti-inflammatory actions, the components of Azerizin possess potent antimicrobial activity against Propionibacterium acnes and Staphylococcus epidermis, at least in part attributed to inhibition of microbial cellular protein synthesis. Azerizin was developed by scientists at Elorac, Inc. for use as an adjunct in the management of acne vulgaris and rosacea.
^Fivenson, DP (Jan 2006). "The mechanisms of action of nicotinamide and zinc in inflammatory skin disease". Cutis ((1 Suppl)): 5–10.
^Jurenka, Julie S (2 Nov 2009). "Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research". Alternative Medicine Review14 (f2): 141–153.
^Shalita, A; Falcon R; Olansky A; Oannotta P; Akhavan A; Day D; Janiga A; Singri P; Kallal J (2012). "Inflammatory acne management with a novel prescription dietary supplement". J of Drugs in Derm11.
^Fitton, Andrew; Goa, Karen L (1991). "Azelaic acid: A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders". Drugs41 (5): 780–798. doi:10.2165/00003495-199141050-00007. PMID1712709.